Literature DB >> 15591082

Clinical evaluation of a viscoelastic gel for reduction of adhesions following gynaecological surgery by laparoscopy in Europe.

P Lundorff1, J Donnez, M Korell, A J M Audebert, K Block, G S diZerega.   

Abstract

BACKGROUND: Commonly used adhesion prevention devices either cannot be applied or are difficult to use via laparoscopy. A viscoelastic gel was developed specifically for adhesion prophylaxis during minimally invasive surgery.
METHODS: Randomized, third party-blinded, parallel-group design conducted at four centres. Patients (18-46 years old) underwent laparoscopic surgery with second look 6-10 weeks later. Viscoelastic gel coated adnexa and adjacent tissues. Blinded reviews of videotapes were quantified by American Fertility Society (AFS) adhesion scores.
RESULTS: In 25 treatment patients, surgery was performed on 45 adnexa. Coverage of surgical sites at risk for adhesions was typically accomplished with approximately 15 ml of viscoelastic gel which was delivered in approximately 90 s. In 24 control patients, surgery alone was performed on 41 adnexa. Treated adnexa showed a decrease in AFS score (11.9-9.1). In contrast, control adnexa showed an increase in AFS score (8.8-15.8). This difference in second-look AFS scores (42% reduction) is significant (P<0.01). Ninety-three per cent of treated adnexa did not have a worse adhesion score in contrast to 56% of control adnexa. Combining scores into prognostic categories also show significant treatment effect of the viscoelastic gel (P<0.01).
CONCLUSION: Viscoelastic gel was easy to use via laparoscopy and produced significant reduction in adnexal adhesions. It provides benefits to patients undergoing gynaecological surgery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15591082     DOI: 10.1093/humrep/deh651

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

Review 1.  Current strategies and future perspectives for intraperitoneal adhesion prevention.

Authors:  Christoph Brochhausen; Volker H Schmitt; Constanze N E Planck; Taufiek K Rajab; David Hollemann; Christine Tapprich; Bernhard Krämer; Christian Wallwiener; Helmut Hierlemann; Rolf Zehbe; Heinrich Planck; C James Kirkpatrick
Journal:  J Gastrointest Surg       Date:  2012-06       Impact factor: 3.452

Review 2.  A review of the problematic adhesion prophylaxis in gynaecological surgery.

Authors:  Anja Hirschelmann; Garri Tchartchian; Markus Wallwiener; Andreas Hackethal; Rudy Leon De Wilde
Journal:  Arch Gynecol Obstet       Date:  2011-10-30       Impact factor: 2.344

3.  Inhibition of adhesion, proliferation, and invasion of primary endometriosis and endometrial stromal and ovarian carcinoma cells by a nonhyaluronan adhesion barrier gel.

Authors:  Stefan P Renner; Pamela L Strissel; Matthias W Beckmann; Johannes Lermann; Stefanie Burghaus; Janina Hackl; Peter A Fasching; Reiner Strick
Journal:  Biomed Res Int       Date:  2015-02-15       Impact factor: 3.411

4.  A first-in-human, randomized, controlled, subject- and reviewer-blinded multicenter study of Actamax™ Adhesion Barrier.

Authors:  Geoffrey H Trew; George A Pistofidis; Sara Y Brucker; Bernhard Krämer; Nicole M Ziegler; Matthias Korell; Henning Ritter; Alex McConnachie; Ian Ford; Alison M Crowe; Trudy D Estridge; Michael P Diamond; Rudy L De Wilde
Journal:  Arch Gynecol Obstet       Date:  2016-11-14       Impact factor: 2.344

5.  Effect of reactive oxygen species scavengers, antiinflammatory drugs, and calcium-channel blockers on carbon dioxide pneumoperitoneum-enhanced adhesions in a laparoscopic mouse model.

Authors:  M M Binda; C R Molinas; A Bastidas; P R Koninckx
Journal:  Surg Endosc       Date:  2007-05-04       Impact factor: 3.453

6.  Delivery of Mesenchymal Stem Cells from Gelatin-Alginate Hydrogels to Stomach Lumen for Treatment of Gastroparesis.

Authors:  Binata Joddar; Nishat Tasnim; Vikram Thakur; Alok Kumar; Richard W McCallum; Munmun Chattopadhyay
Journal:  Bioengineering (Basel)       Date:  2018-02-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.